Abstract
Although the excision of unstable pathogenicity islands is a phenomenon that has been described for several virulent bacteria, whether this process directly affects the capacity of these microorganisms to cause disease in their hosts remains unknown. Salmonella enterica serovar Enteritidis (S. Enteritidis) is an enterobacterium that harbors several unstable pathogenicity islands that can excise from the main bacterial chromosome. Here we have evaluated whether excision of one of these pathogenicity islands, denominated as Region of Difference 21 (ROD21), is required for S. Enteritidis to cause disease in the host. By means of genetic targeting of the integrase encoded by the ROD21 we have generated S. Enteritidis strains unable to excise ROD21. The failure to excise ROD21 significantly reduced the capacity to cause a lethal disease and to colonize the spleen and liver of mice, as compared to wild type S. Enteritidis. On the contrary, S. Enteritidis strains overexpressing an excisionase protein increased the frequency of ROD21 excision and showed an improved capacity to cause lethal disease in mice. Accordingly, strains unable to excise ROD21 showed an altered expression of genes located in this pathogenicity island. Our results suggest that the genetic excision of the pathogenicity island ROD21 in S. Enteritidis modulates the capacity of this bacterium to cause disease in mice due to a change in the expression of virulence genes.
Keywords: Pathogenicity island excision, salmonella enterica serovar enteritidis, systemic infection.
Current Gene Therapy
Title:Chromosomal Excision of a New Pathogenicity Island Modulates Salmonella Virulence In Vivo
Volume: 13 Issue: 4
Author(s): Hugo E. Tobar, Franciso J. Salazar-Echegarai, Pamela A. Nieto, Christian E. Palavecino, Vatenlina P. Sebastian, Claudia A. Riedel, Alexis M. Kalergis and Susan M. Bueno
Affiliation:
Keywords: Pathogenicity island excision, salmonella enterica serovar enteritidis, systemic infection.
Abstract: Although the excision of unstable pathogenicity islands is a phenomenon that has been described for several virulent bacteria, whether this process directly affects the capacity of these microorganisms to cause disease in their hosts remains unknown. Salmonella enterica serovar Enteritidis (S. Enteritidis) is an enterobacterium that harbors several unstable pathogenicity islands that can excise from the main bacterial chromosome. Here we have evaluated whether excision of one of these pathogenicity islands, denominated as Region of Difference 21 (ROD21), is required for S. Enteritidis to cause disease in the host. By means of genetic targeting of the integrase encoded by the ROD21 we have generated S. Enteritidis strains unable to excise ROD21. The failure to excise ROD21 significantly reduced the capacity to cause a lethal disease and to colonize the spleen and liver of mice, as compared to wild type S. Enteritidis. On the contrary, S. Enteritidis strains overexpressing an excisionase protein increased the frequency of ROD21 excision and showed an improved capacity to cause lethal disease in mice. Accordingly, strains unable to excise ROD21 showed an altered expression of genes located in this pathogenicity island. Our results suggest that the genetic excision of the pathogenicity island ROD21 in S. Enteritidis modulates the capacity of this bacterium to cause disease in mice due to a change in the expression of virulence genes.
Export Options
About this article
Cite this article as:
Tobar E. Hugo, Salazar-Echegarai J. Franciso, Nieto A. Pamela, Palavecino E. Christian, Sebastian P. Vatenlina, Riedel A. Claudia, Kalergis M. Alexis and Bueno M. Susan, Chromosomal Excision of a New Pathogenicity Island Modulates Salmonella Virulence In Vivo, Current Gene Therapy 2013; 13 (4) . https://dx.doi.org/10.2174/1566523211313040002
DOI https://dx.doi.org/10.2174/1566523211313040002 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature
Cardiovascular & Hematological Agents in Medicinal Chemistry p53-Induced Apoptosis and Inhibitors of p53
Current Medicinal Chemistry HIV Vaccines in Infants and Children: Past Trials, Present Plans and Future Perspectives
Current Molecular Medicine Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients
Current Vascular Pharmacology subject Index To Volume 2
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Synthesis and Antiviral Activity of 2-aryl-4H-chromen-4-one Derivatives Against Chikungunya Virus
Letters in Drug Design & Discovery Humoral Immunity in Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Possibilities of Poly(D,L-lactide-co-glycolide) in the Formulation of Nanomedicines Against Cancer
Current Drug Targets Therapeutic Approach of Primary Bone Tumours by Bisphosphonates
Current Pharmaceutical Design Editorial [Thematic Issue: Structural Characteristics of Short Peptides Solution Recombinant Therapeutic Protein Vaccines]
Protein & Peptide Letters Crosstalk Between Calpain and Calcineurin in Excitotoxic Neurodegeneration; Therapeutic Targets for the Treatment of Excitotoxic Neurodegeneration
Current Medicinal Chemistry - Central Nervous System Agents <i>Boswellia carterii</i> Liquisolid Systems with Promoted Anti-inflammatory Activity
Current Drug Delivery Mechanism by which Regulatory Rheumatoid Factor Prevents Experimental Autoimmune Encephalomyelitis
Endocrine, Metabolic & Immune Disorders - Drug Targets Antibody-Mediated Endothelial Cell Damage Via Nitric Oxide
Current Pharmaceutical Design Murabutide Revisited: A Review of its Pleiotropic Biological Effects
Current Medicinal Chemistry Herba Epimedii: An Ancient Chinese Herbal Medicine in the Prevention and Treatment of Osteoporosis
Current Pharmaceutical Design Recent Evidence of the Regulatory Role of PPARs in Neural Stem Cells and Their Underlying Mechanisms for Neuroprotective Effects
Current Stem Cell Research & Therapy Natural Moieties as Anti-Inflammatory Agents-Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery How to Generate Reliable and Predictive CoMFA Models
Current Medicinal Chemistry Use of Virostatics as a Means of Targeting Human Immunodeficiency Virus Infection
Current Pharmaceutical Design